Fibromyalgia

The diagnosis and management of fibromyalgia (FM) have undergone a significant shift in recent years. The FDA's approval of several agents with a specific indication in FM has brought this once and still controversial diagnosis to the forefront of clinical and basic science research efforts on the pathophysiology of chronic pain. There has been significant progress in understanding of the pathogenesis of chronic pain conditions, including fibromyalgia and concurrent renewedefforts to update current clinical practice guidelines. Part of the Oxford American Pocket Cards series, this concise, ultra-portable, up-to-date and attractively designed medical reference card provides essential clinical tools to aid the busy clinician in the diagnosis and treatment of fibromyalgia at the point of care. To purchase this product, please contact U.S. Medical Sales at MedSales@oup.com